Original Research

Published on 15 Sep 2023

Effects of smoking cessation on plasma clozapine concentrations in male patients with schizophrenia during the COVID-19 pandemic

in Psychopharmacology

Botao Ma
Hongzhen Fan
Siyuan Qi
Fude Yang
Huimei An

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1256264

1,616 views

Original Research

Published on 30 Aug 2023

Reductions in anxiety and depression symptoms in a subset of outpatients with problematic substance use who received ketamine-assisted psychotherapy: a two-year retrospective chart review

in Psychopharmacology

Emily Whinkin
Therry Rose J. Eparwa
Michelle C. Julseth
Andrea Schneider
Sunil K. Aggarwal

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1160442

3,007 views

Editorial

Published on 21 Aug 2023

Editorial: Community series in novel antipsychotics within and beyond clinical trials: symptom-based treatment of psychiatric disorders with D3-D2 partial agonists, volume II

in Psychopharmacology

Peter Falkai
Zsófia Borbála Dombi

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1266566

1,079 views

Original Research

Published on 21 Aug 2023

Individually tailored dosage regimen of full-spectrum Cannabis extracts for autistic core and comorbid symptoms: a real-life report of multi-symptomatic benefits

in Psychopharmacology

Patrícia Soares Silva Montagner
Wesley Medeiros
Leandro Cruz Ramires da Silva
Clarissa Nogueira Borges
Joaquim Brasil-Neto
Vinícius de Deus Silva Barbosa
Fabio V. Caixeta
Renato Malcher-Lopes

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1210155

9,649 views
5 citations

Editorial

Published on 14 Aug 2023

Editorial: Bridging the gap: an interdisciplinary perspective on ketamine in psychiatric disorders

in Psychopharmacology

Glenn Hartelius
Sherry-Anne Muscat
Lucie Bartova

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1246891

2,667 views
3 citations

Case Report

Published on 07 Aug 2023

Case report: application of pharmacogenetics in the personalized treatment of an elderly patient with a major depressive episode

in Psychopharmacology

Milica Pjevac
Sara Redenšek Trampuž
Tanja Blagus
Vita Dolžan
Jurij Bon

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1250253

2,858 views
2 citations

Systematic Review

Published on 04 Aug 2023

Magnitude of placebo response in clinical trials of paroxetine for vasomotor symptoms: a meta-analysis

in Psychopharmacology

Joshua R. Rhodes
Cameron T. Alldredge
Gary R. Elkins

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1204163

2,784 views
1 citation

Case Report

Published on 31 Jul 2023

A case report—“When less is more”: controlled inpatient reduction of anticholinergic burden in a patient with clozapine-resistant schizophrenia

in Psychopharmacology

Milica Pjevac
Liam Korošec Hudnik

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1222177

2,007 views
2 citations

Case Report

Published on 27 Jul 2023

Case report: Hyperactive delirium after a single dose of zolpidem administered additionally to psychopharmacotherapy including clozapine

in Psychopharmacology

Maximilian Preiss
Ulrich Rabl
Valentin Popper
Victoria Watzal
Michael Treiber
Dominik Ivkic
Nicole Praschak-Rieder
Angela Naderi-Heiden
Gernot Fugger
Richard Frey

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1204009

2,368 views
1 citation

Original Research

Published on 14 Jul 2023

Attitudes, beliefs, and knowledge regarding medical cannabis among healthcare students in the Republic of Cyprus: a cross-sectional descriptive correlational study

in Psychopharmacology

Sokratis Sokratous
Meropi Mpouzika
Katerina Kaikoushi
George Alexandrou
Maria Karanikola

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1196915

3,065 views
1 citation

Case Report

Published on 13 Jul 2023

Pathophysiology and management of risperidone-induced sialorrhea: case report

in Psychopharmacology

Tyler Torrico
Angad Kahlon

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1185750

5,289 views
3 citations

Systematic Review

Published on 12 Jul 2023

The potential effect of metformin on cognitive and other symptom dimensions in patients with schizophrenia and antipsychotic-induced weight gain: a systematic review, meta-analysis, and meta-regression

in Psychopharmacology

Vera Battini
Giovanna Cirnigliaro
Rodolfo Leuzzi
Eleonora Rissotto
Giulia Mosini
Beatrice Benatti
Marco Pozzi
Maria Nobile
Sonia Radice
Carla Carnovale

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1215807

6,613 views
7 citations

Brief Research Report

Published on 10 Jul 2023

Potential biomarker of brain response to opioid antagonism in adolescents with eating disorders: a pilot study

in Psychopharmacology

Stephani L. Stancil
Hung-Wen Yeh
Morgan G. Brucks
Amanda S. Bruce
Michaela Voss
Susan Abdel-Rahman
William M. Brooks
Laura E. Martin

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1161032

2,063 views
1 citation

Perspective

Published on 07 Jul 2023

Perceived key change phenomena of MDMA-assisted psychotherapy for the treatment of severe PTSD: an interpretative phenomenological analysis of clinical integration sessions

in Psychopharmacology

Macha Godes
Jasper Lucas
Eric Vermetten

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.957824

5,837 views
4 citations

Case Report

Published on 03 Jul 2023

Case report: Interstitial pneumonitis after initiation of lamotrigine

in Psychopharmacology

Victoria Watzal
Godber Mathis Godbersen
Ana Weidenauer
Matthäus Willeit
Valentin Popper
Michael Treiber
Maximilian Preiss
Dominik Ivkic
Ulrich Rabl
Gernot Fugger

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1203497

2,441 views
2 citations

Original Research

Published on 30 Jun 2023

EPD1504: a novel μ-opioid receptor partial agonist attenuates obsessive–compulsive disorder (OCD)-like behaviors

in Psychopharmacology

Beth Youngblood
Julio C. Medina
Donald R. Gehlert
Neil Schwartz

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1170541

3,799 views
1 citation

Navigation group

Articles

Effects of smoking cessation on plasma clozapine concentrations in male patients with schizophrenia during the COVID-19 pandemic

Reductions in anxiety and depression symptoms in a subset of outpatients with problematic substance use who received ketamine-assisted psychotherapy: a two-year retrospective chart review

Editorial: Community series in novel antipsychotics within and beyond clinical trials: symptom-based treatment of psychiatric disorders with D3-D2 partial agonists, volume II

Individually tailored dosage regimen of full-spectrum Cannabis extracts for autistic core and comorbid symptoms: a real-life report of multi-symptomatic benefits

Editorial: Bridging the gap: an interdisciplinary perspective on ketamine in psychiatric disorders

Case report: application of pharmacogenetics in the personalized treatment of an elderly patient with a major depressive episode

Magnitude of placebo response in clinical trials of paroxetine for vasomotor symptoms: a meta-analysis

A case report—“When less is more”: controlled inpatient reduction of anticholinergic burden in a patient with clozapine-resistant schizophrenia

Case report: Hyperactive delirium after a single dose of zolpidem administered additionally to psychopharmacotherapy including clozapine

Attitudes, beliefs, and knowledge regarding medical cannabis among healthcare students in the Republic of Cyprus: a cross-sectional descriptive correlational study

Pathophysiology and management of risperidone-induced sialorrhea: case report

The potential effect of metformin on cognitive and other symptom dimensions in patients with schizophrenia and antipsychotic-induced weight gain: a systematic review, meta-analysis, and meta-regression

Potential biomarker of brain response to opioid antagonism in adolescents with eating disorders: a pilot study

Perceived key change phenomena of MDMA-assisted psychotherapy for the treatment of severe PTSD: an interpretative phenomenological analysis of clinical integration sessions

Case report: Interstitial pneumonitis after initiation of lamotrigine

EPD1504: a novel μ-opioid receptor partial agonist attenuates obsessive–compulsive disorder (OCD)-like behaviors